Deutsche Bank’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
Other funds holding TARA
Deutsche Bank's TARA Position: Q3 2026 in Review
Deutsche Bank reduced its Protara Therapeutics (TARA) stake by 13% in Q3 2026, selling an estimated $28.4K and leaving 50,423 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #3222.
Deutsche Bank first reported a position in TARA in Q4 2014 and has held it in 17 quarters since. The position peaked at $281K in Q1 2026. 61 funds tracked by Wall St. Rank hold TARA as of Q3 2026.
- Deutsche Bank held 50,423 shares of Protara Therapeutics worth $154K as of Q3 2026.
- Deutsche Bank sold 7,290 Protara Therapeutics shares in Q3 2026, an estimated $28.4K.
- Protara Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #3222 holding.
- Deutsche Bank first reported a position in Protara Therapeutics in Q4 2014 and has held it in 17 quarters since.
- Deutsche Bank's Protara Therapeutics position peaked at $281K in Q1 2026.
- 61 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2026.
Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.